13. If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to (A) design a compound that mimics epinephrine and can bind to the epinephrine receptor (B) design a compound that stimulates cAMP production in liver cells (C) design a compound to stimulate G protein activity in liver cells (D) design a compound that increases phosphodiesterase activity